Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,755.20
(
-1.56%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
108.82
(
2.10%
)
Bitcoin
70,960.00
(
-0.37%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

microcapfun

Send PM Follow Ignore
Followers 6
Posts 560
Boards Moderated 0
Alias Born 03/13/2007

microcapfun

Re: DewDiligence post# 3926

Monday, 06/25/2007 4:03:44 PM

Monday, June 25, 2007 4:03:44 PM

Post# of 19309
>>Returning to your example of the IFN-alpha drugs, it’s worth noting that SGP’s archaic Intron-A continues to rack up annual sales in the hundreds of millions of dollars.<<

Pegasys and PegIntron have >95% market share. That of course means the non-pegylated IF-alphas have < 5% market share. Could be well below 5% market share; I'm not sure.

micro

Life is an IQ test.

email: microcapfun@yahoo.com

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now